Skip to content

Effects of Ear Acupuncture and Cupping Therapy with glasses on Back Pain

Effects of Auricular Acupuncture and Cupping Therapy on Chronic Back Pain: Randomized Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9h77k7
Enrollment
Unknown
Registered
2017-10-16
Start date
2017-12-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Back pain

Interventions

Active control group 1 (Auricular acupuncture) - 100 subjects, male and female, will receive atrial acupuncture with sterile and disposable semipermanent needles, alternating the auricular pavilion at
Other
E02.190.044.133
E02.190.044

Sponsors

Universidade Federal de Minas Gerais
Lead Sponsor
Universidade Federal de Minas Gerais
Collaborator

Eligibility

Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age (between 18 and 80 years); orientation in time, space and person; presence of chronic pain in the vertebral column for three months or more, of any origin; self-report of pain intensity bigger or equal 4, and availability of time for submission to treatment sessions.

Exclusion criteria

Exclusion criteria: Infection, inflammation or injury in the ear; use of piercing (except normal earring); allergy to metal or micropore; decreased skin turgor, skin lesions or diseases in the dorsal region; treatments with anticoagulant; use of other energy therapies (massage, herbal medicine, reiki, floral therapy) up to three months prior to the study; physiotherapy treatment concomitant with the proposed interventions; continuous use of medication for pain relief; neurological, psychiatric or rheumatic disease; pregnancy; breastfeeding; and not respond to three attempts of contact made by the researcher.

Design outcomes

Primary

MeasureTime frame
Intensity of chronic pain, verified by means of the Brief Pain Inventory, from the observation of a variation of at least 2 points in the pre- and post-intervention measurements. The primary outcome will be assessed before starting treatment sessions and after each session, and seven, 15 days and 30 days after the end of the procedure.

Secondary

MeasureTime frame
Interference in daily activities, verified through the Brief Inventory of Pain, evaluated before starting the treatment sessions and after each session, and 7, 15 days and 30 days after the end of the procedure. An improvement in pain interference is expected in patients' daily activities. ;Physical disability, verified by Rolland Morris Disability Questionnaire for general pain, assessed prior to initiating treatment sessions and after each session, and seven, 15 days, and 30 days after the end of the procedure. An improvement in the patients' physical disability is expected. ;Quality of life, verified through the Medical Outcomes Study 36 - Item short-form health survey (SF-36), evaluated before starting the treatment sessions and after each session, and seven, 15 days and 30 days after the end of the procedure. The quality of life of patients is expected to improve.;Nociceptive threshold, verified by a digital algometer, evaluated before starting the treatment sessions and after each session, and seven, 15 days and 30 days after the end of the procedure. An increase in the nociceptive threshold of patients is expected.

Countries

Brazil

Contacts

Public ContactTânia Chianca

Universidade Federal de Minas Gerais

taniachianca@gmail.com+55(31)34099887

Outcome results

None listed

Source: REBEC (via WHO ICTRP)